CN111610328A - Self-service detection station for disease primary screening - Google Patents
Self-service detection station for disease primary screening Download PDFInfo
- Publication number
- CN111610328A CN111610328A CN202010442578.8A CN202010442578A CN111610328A CN 111610328 A CN111610328 A CN 111610328A CN 202010442578 A CN202010442578 A CN 202010442578A CN 111610328 A CN111610328 A CN 111610328A
- Authority
- CN
- China
- Prior art keywords
- detection
- self
- service
- sentry box
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 143
- 201000010099 disease Diseases 0.000 title claims abstract description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 38
- 238000012216 screening Methods 0.000 title abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 66
- 238000012360 testing method Methods 0.000 claims abstract description 16
- 238000004659 sterilization and disinfection Methods 0.000 claims description 20
- 238000007689 inspection Methods 0.000 claims description 18
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 241000711573 Coronaviridae Species 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 6
- 230000000249 desinfective effect Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 241001678559 COVID-19 virus Species 0.000 claims description 3
- 241000711549 Hepacivirus C Species 0.000 claims description 3
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 3
- 208000002672 hepatitis B Diseases 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 230000005540 biological transmission Effects 0.000 claims description 2
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 238000000889 atomisation Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04H—BUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
- E04H9/00—Buildings, groups of buildings or shelters adapted to withstand or provide protection against abnormal external influences, e.g. war-like action, earthquake or extreme climate
- E04H9/16—Buildings, groups of buildings or shelters adapted to withstand or provide protection against abnormal external influences, e.g. war-like action, earthquake or extreme climate against adverse conditions, e.g. extreme climate, pests
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/04—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for anthropometrical measurements, such as weight, height, strength
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/186—Hepatitis C; Hepatitis NANB
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Architecture (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Business, Economics & Management (AREA)
- General Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Emergency Management (AREA)
- Environmental & Geological Engineering (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention discloses a self-service detection station for disease preliminary screening, which relates to the technical field of health and epidemic prevention and comprises a detection reagent supply platform and at least one self-service detection platform arranged beside the detection reagent supply platform; the detection reagent supply platform is used for supplying detection reagents to users for compensation or compensation; self-service testing platform supplies the user to carry out self-service detection operation, and self-service testing platform is equipped with detection processor, and this detection processor is used for automatic identification and handles the testing result of detect reagent. The self-service detection station provided by the invention integrates the detection reagent supply platform and the self-service detection platform, so that a user can conveniently obtain the detection reagent and carry out self-service detection, the purpose of disease primary screening is achieved, the user can diagnose and treat in time, the medical time of the user is greatly shortened, the detection efficiency is improved, the trouble of long hospital formation and difficulty in seeing is eliminated, and the pressure of the hospital is effectively relieved.
Description
Technical Field
The invention relates to the technical field of health epidemic prevention, in particular to a self-service detection station for disease primary screening.
Background
Various new coronavirus detection kits are provided in the market at present, and can quickly and accurately detect new coronavirus, so that the detection efficiency of a first-line medical institution is effectively improved.
However, in the period of epidemic prevention and control, medical resources and human resources of hospitals are very deficient, and if people have suspected symptoms, the people can directly go to the hospitals to carry out related detection, so that not only is pressure on the hospitals increased, but also the risk of cross infection exists. Therefore, how to use the new coronavirus detection kit scientifically and reasonably to enable people to perform preliminary self-screening timely, safely, reliably and normatively when suspected symptoms exist is very important.
Based on this, we provide a self-service detection station that is used for disease preliminary screening that can extensively be applied to multiple occasion.
Disclosure of Invention
The invention provides a self-service detection station for disease preliminary screening, and mainly aims to solve the problems.
The invention adopts the following technical scheme:
a self-service detection station for disease preliminary screening comprises a detection reagent supply platform and at least one self-service detection platform arranged beside the detection reagent supply platform; the detection reagent supply platform is used for supplying detection reagents to users for a fee or a fee; the self-service detection platform is used for a user to perform self-service detection operation, and is provided with a detection processor which is used for automatically identifying and processing the detection result of the detection reagent.
Further, the self-service detection station also comprises a user terminal, wherein the detection processor is in communication connection with the user terminal, and sends a detection result to the user terminal.
Furthermore, the detection reagent supply platform is a self-service vending machine, and the self-service vending machine is in communication connection with the user terminal.
Further, this self-service inspection station still includes and illness accuse center, above-mentioned detection treater with above-mentioned illness accuse center interconnect to when preset disease epidemic situation appears in user's testing result, with disease epidemic situation transmission to doing all can and accusing the center.
Further, the self-service detection platform comprises a safety sentry box and the detection processor arranged in the safety sentry box; the packaging box of the detection reagent is provided with a unique bar code; the safety sentry box is provided with an electronic door, and the electronic door is provided with an identification device for identifying the bar code.
Further, this self-service testing platform still includes the degassing unit who is used for carrying out disinfection treatment to safety sentry box inside.
Furthermore, the sterilizing device comprises an ultraviolet sterilizing lamp and an atomizing sterilizer; the ultraviolet disinfection lamp is arranged at the top of the safety sentry box and is used for deeply disinfecting the interior of the safety sentry box; above-mentioned atomizing sterilizing machine sets up in the inside wall of safety sentry box for carry out quick disinfection to safety sentry box inside and handle.
Further, the self-service detection platform also comprises an operation table and a folding chair which are arranged inside the safety sentry box; the operating platform is fixedly arranged on the inner side wall of the safety sentry box, and the detection processor is placed on the operating platform; the folding chair is arranged beside the operating table in a foldable manner.
Further, the detection reagent is one or more of a 2019-nCoV novel coronavirus detection reagent, an HIV human immunodeficiency virus antibody detection reagent, an HBV hepatitis B five detection reagent and an HCV hepatitis C virus antibody detection reagent.
Further, above-mentioned detect reagent supply platform is artifical selling sentry box.
Compared with the prior art, the invention has the beneficial effects that:
firstly, the self-service detection station provided by the invention integrates the detection reagent supply platform and the self-service detection platform, so that a user can conveniently obtain the detection reagent and carry out self-service detection, the purpose of disease primary screening is achieved, the user can diagnose and treat in time, the medical time of the user is greatly shortened, the detection efficiency is improved, the trouble that a hospital is long in queue and is difficult to see is eliminated, and the pressure of the hospital is effectively relieved.
Secondly, the invention can be mutually communicated and connected with the disease control center through the detection processor, and when the detection result of the user has the preset disease epidemic situation, the disease epidemic situation can be timely fed back to the disease control center, so that the disease control center is assisted to diagnose, treat, isolate or control the patient, and the spread of the disease situation is effectively prevented.
Thirdly, the self-service detection platform adopts a safety sentry box with extremely high privacy, the privacy of the user is fully guaranteed, and a complete and efficient disinfection device is arranged in the safety sentry box, so that the interior of the safety sentry box can be effectively disinfected in time, and a safe and healthy detection environment is provided for the user.
Fourthly, the self-service detection station provided by the invention has a simple structure, is convenient to use, can flexibly adopt various 1+ N assembly modes according to actual needs, and can be widely applied to various occasions such as communities, hospitals, schools, sports halls, entertainment halls and the like.
The self-service detection station provided by the invention adopts fingertip blood as a detection sample and antibody detection as a method, and can be used for detecting at any time without the presence of professional inspection personnel, so that the operation is simple, the safety and the efficiency are high, the detection rate is high, and the self-service detection station not only can be used for primarily screening new coronavirus, but also can provide effective help for primarily self-detecting various infectious diseases, inflammations, cardiovascular diseases and the like in the late epidemic situation period.
Drawings
Fig. 1 is a schematic block diagram of a first embodiment of the present invention.
Fig. 2 is a schematic overall structure diagram of a first embodiment of the present invention.
Fig. 3 is a first perspective view of a first embodiment of the present invention.
Fig. 4 is a second perspective view of the first embodiment of the invention.
Fig. 5 is a schematic overall structure diagram of a second embodiment of the present invention.
Detailed Description
The following describes embodiments of the present invention with reference to the drawings. Numerous details are set forth below in order to provide a thorough understanding of the present invention, but it will be apparent to those skilled in the art that the present invention may be practiced without these details.
The first embodiment is as follows:
referring to fig. 1 to 4, a self-service inspection station for disease preliminary screening comprises an inspection reagent supply platform 1 and self-service inspection platforms 2 arranged at two sides of the inspection reagent supply platform 1; the detection reagent supply platform 1 is used for supplying detection reagents to users for a fee or a fee; the self-service detection platform 2 is used for a user to carry out self-service detection operation, and the self-service detection platform is provided with a detection processor 21, and the detection processor 21 is used for automatically identifying and processing a detection result of a detection reagent. The user obtains testing reagent through testing reagent supply platform 1 to go on self-service testing operation to self-service testing platform 2, specifically, testing reagent includes sampling device and reagent card, and the user carries out self-service sampling operation through sampling device, then adds the sample of gathering to the reagent card, and discerns and handles the testing result through detection processor 21.
Referring to fig. 1 to 4, the self-service detection station further comprises a user terminal 3, and the detection processor 21 is in communication connection with the user terminal 3 and sends the detection result to the user terminal 3. After the user finishes the relevant operation of self-service sampling at the self-service detection platform 2, the reagent card is placed in the specified card slot of the detection processor 21 and can leave, the detection processor 21 can automatically identify and process the detection result of the reagent card and send the detection result to the user terminal 3, so that the waiting time of the user can be fully shortened, and the detection efficiency is improved. As a preferred scheme, the user terminal is a smart phone.
Referring to fig. 1 to 4, the detection reagent supply platform 1 is a vending machine, which is communicatively connected to the user terminal 3. The user can remotely inquire the selling condition of the detection reagent through the user terminal 4, and can also pre-order the detection reagent in advance or buy the detection reagent on site through the user terminal 4.
Referring to fig. 1 to 4, the self-service inspection station further includes a disease control center 4, and the inspection processor 21 is in communication connection with the disease control center 4 and transmits a disease epidemic situation to the disease control center 4 when a preset disease epidemic situation occurs in the inspection result of the user. Therefore, the disease control center 4 can quickly know the disease epidemic situation, so as to carry out relevant diagnosis, treatment, isolation or control and the like on the sick person in time. However, in the late epidemic situation, in order to improve privacy and fully guarantee the privacy interests of the user, the data sharing method of the detection processor 21 may be designed in a customized manner, for example: the data sharing channel between the detection processor 21 and the disease control center 4 may be selected to be shut down and the detection processor 21 does not store any detection information.
Referring to fig. 1-4, the self-service detection platform 2 includes a security kiosk 20 and a detection processor 21 disposed within the security kiosk. The package of test reagents is provided with a unique bar code, the security kiosk 20 is provided with an electronic door 26, and the electronic door 26 is provided with an identification means (not shown) for identifying the bar code. The user passes through the bar code on the recognition device discernment detect reagent packing carton, and the electron door just can be opened after discernment passes through to go into in the safety sentry box and carry out detection operation. The design can fully improve the privacy and the safety of the safety sentry box 20 and effectively ensure the personal rights and interests of users.
Referring to fig. 1 to 4, the self-service testing platform 2 further comprises a disinfection device for disinfecting the interior of the security kiosk 20. Specifically, the sterilizing device includes an ultraviolet sterilizing lamp 22 and an atomizing sterilizer 23; the ultraviolet disinfection lamp 22 is arranged at the top of the safety sentry box 20 and is used for carrying out deep disinfection treatment on the interior of the safety sentry box 20; atomizing sterilization machine 23 sets up in the inside wall of safety sentry box 20 for carry out quick disinfection processing to safety sentry box 20 inside. The electronic door 26 is provided with a control panel (not shown in the figure) for controlling the ultraviolet disinfection lamp 22 and the atomization disinfection machine 23, a manager can regularly perform deep disinfection treatment on the interior of the safety sentry box 20 through the ultraviolet disinfection lamp 22, before a user enters the safety sentry box 20, the atomization disinfection machine 23 can perform rapid disinfection treatment on the interior of the safety sentry box 20, in the disinfection treatment process, the electronic door 26 is tightly closed, the user cannot enter the safety sentry box 20, therefore, the safety of the safety sentry box 20 can be fully improved, and a safe and healthy detection environment is provided for the user.
Referring to fig. 1 to 4, the self-service detection platform 2 further includes an operation table 24 and a folding chair 25 disposed inside the safety sentry box 20; the operation platform 24 is fixedly arranged on the inner side wall of the safety sentry box 20, and the detection processor 21 is arranged on the operation platform 24; the folding chair 25 is foldably provided beside the console 24. In addition, the safety sentry box 20 is also internally provided with an air conditioner 27, an exhaust fan 28, a clothes and hat hanger 29 and the like, which are used for improving the humanized design of the user experience.
Referring to fig. 1 to 4, as a preferred embodiment: the detection reagent is one or more of 2019-nCoV novel coronavirus detection reagent, HIV human immunodeficiency virus antibody detection reagent, HBV hepatitis B five detection reagent and HCV hepatitis C virus antibody detection reagent. The method adopts the fingertip blood as a detection sample and the antibody detection as a method, and can be detected at any time without the presence of professional inspectors, so that the method is simple to operate, safe, efficient and high in detection rate.
With reference to fig. 1 to 3, the following describes a specific operation of the present embodiment:
(1) the user purchases the detection reagent through the user terminal 3 or directly through the vending machine.
(2) The user goes to the outside of the safety sentry box 20 and selects the atomizing sterilizer 23 to perform rapid sterilization treatment on the inside of the safety sentry box 20 through the control panel.
(3) After the disinfection treatment, the user identifies the bar code information on the detection reagent packaging box through the identification device on the electronic door 26; after the identification is passed, the electronic door 26 is opened, and the user enters the security sentry box 20 for self-service detection operation.
(4) The inside wall of the safety sentry box 20 is provided with an operation guide indication board, a user completes fingertip blood sampling operation according to steps according to operation guide, a collected sample is added to the reagent card, and finally the reagent card is placed in a specified card slot of the detection processor 21 so as to leave.
(5) The detection processor 21 automatically identifies and compares the detection result of the reagent card, and sends the final detection result to the user terminal 3.
Example two:
referring to fig. 1 to 5, unlike the first embodiment, the detection reagent supply platform 1 is an artificial vending kiosk. When the personnel flow in the bigger occasion (such as entrance of sports meeting place, entrance of entertainment meeting place, entrance of meeting place for politics and economy at home and abroad), the manual selling mode can be adopted, the table and chair and the freezer for storing the detection reagent are configured in the manual selling sentry box, and the medical personnel are equipped according to the requirement, thereby being convenient for providing face-to-face detection consultation service for the user and being beneficial to realizing the on-site supervision and management.
It should be noted that, in addition to the above two embodiments, in the production process, a 1+ N structural form may be adopted according to actual needs, that is, a self-service detection station may be designed in a manner that one detection reagent supply platform 1 is configured with one or more self-service detection platforms 2, so as to fully adapt to different use occasions.
The above description is only an embodiment of the present invention, but the design concept of the present invention is not limited thereto, and any insubstantial modifications made by using the design concept should fall within the scope of infringing the present invention.
Claims (10)
1. The utility model provides a self-service station that detects for disease prescreening which characterized in that: comprises a detection reagent supply platform and at least one self-service detection platform arranged beside the detection reagent supply platform; the test reagent supply platform is used for supplying test reagents to users for a fee or a fee; the self-service detection platform is used for a user to carry out self-service detection operation, and the self-service detection platform is provided with a detection processor which is used for automatically identifying and processing the detection result of the detection reagent.
2. The self-service inspection station for disease prescreening of claim 1, wherein: the detection processor is in communication connection with the user terminal and sends a detection result to the user terminal.
3. The self-service inspection station for disease prescreening of claim 2, wherein: the detection reagent supply platform is a self-service vending machine, and the self-service vending machine is in communication connection with the user terminal.
4. The self-service inspection station for disease prescreening of claim 1, wherein: still include and do all can the center, the detection treater with control all can the center intercommunication connection to when the preset disease epidemic situation appears in user's testing result, with disease epidemic situation transmission to control all can the center.
5. The self-service inspection station for disease prescreening of claim 1, wherein: the self-service detection platform comprises a safety sentry box and the detection processor arranged in the safety sentry box; the packaging box of the detection reagent is provided with a unique bar code; the safety sentry box is provided with an electronic door, and the electronic door is provided with an identification device for identifying the bar code.
6. The self-service inspection station for disease prescreening of claim 5, wherein: the safety sentry box further comprises a disinfection device used for disinfecting the interior of the safety sentry box.
7. The self-service inspection station for disease prescreening of claim 6, wherein: the sterilizing device comprises an ultraviolet sterilizing lamp and an atomizing sterilizer; the ultraviolet disinfection lamp is arranged at the top of the safety sentry box and is used for deeply disinfecting the interior of the safety sentry box; the atomizing sterilizer is arranged on the inner side wall of the safety sentry box and is used for rapidly sterilizing the interior of the safety sentry box.
8. The self-service inspection station for disease prescreening of claim 5, wherein: the safety sentry box comprises a safety sentry box body, a folding seat and a control panel, wherein the safety sentry box body is arranged on the top of the sentry box body; the operation table is fixedly arranged on the inner side wall of the safety sentry box, and the detection processor is placed on the operation table; the folding chair is arranged beside the operating platform in a foldable manner.
9. The self-service inspection station for disease prescreening of claim 1, wherein: the detection reagent is one or more of 2019-nCoV novel coronavirus detection reagent, HIV human immunodeficiency virus antibody detection reagent, HBV hepatitis B five detection reagent and HCV hepatitis C virus antibody detection reagent.
10. The self-service inspection station for disease prescreening of claim 1, wherein: the detection reagent supply platform is a manual selling sentry box.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010442578.8A CN111610328A (en) | 2020-05-22 | 2020-05-22 | Self-service detection station for disease primary screening |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010442578.8A CN111610328A (en) | 2020-05-22 | 2020-05-22 | Self-service detection station for disease primary screening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111610328A true CN111610328A (en) | 2020-09-01 |
Family
ID=72199577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010442578.8A Pending CN111610328A (en) | 2020-05-22 | 2020-05-22 | Self-service detection station for disease primary screening |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111610328A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112767611A (en) * | 2021-02-19 | 2021-05-07 | 安徽阿尔梅达健康科技有限公司 | One-stop self-service detection terminal based on reagent is sold |
| CN112820032A (en) * | 2021-02-19 | 2021-05-18 | 安徽阿尔梅达健康科技有限公司 | Self-service detection and selling system based on rapid detection |
| CN113503061A (en) * | 2021-06-17 | 2021-10-15 | 深圳医云互联网医疗科技有限公司 | Healthy cabin equipment that is fit for detecting by oneself |
-
2020
- 2020-05-22 CN CN202010442578.8A patent/CN111610328A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112767611A (en) * | 2021-02-19 | 2021-05-07 | 安徽阿尔梅达健康科技有限公司 | One-stop self-service detection terminal based on reagent is sold |
| CN112820032A (en) * | 2021-02-19 | 2021-05-18 | 安徽阿尔梅达健康科技有限公司 | Self-service detection and selling system based on rapid detection |
| CN113503061A (en) * | 2021-06-17 | 2021-10-15 | 深圳医云互联网医疗科技有限公司 | Healthy cabin equipment that is fit for detecting by oneself |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111610328A (en) | Self-service detection station for disease primary screening | |
| JP7219221B2 (en) | System and method for automatic puncture | |
| WO2021185049A1 (en) | Medical service robot device, and method and system therof | |
| CN212159822U (en) | Self-service detection station for disease primary screening | |
| Berardi et al. | Cross-cultural adaptation and validation in the Italian population of the wolf motor function test in patients with stroke | |
| Stark | Creating disability in the home: The role of environmental barriers in the United States | |
| US20180165417A1 (en) | Bathroom Telemedicine Station | |
| CN112820032A (en) | Self-service detection and selling system based on rapid detection | |
| CN111696633A (en) | Disease prevention and control service system and method based on community health big data | |
| CN112245177A (en) | Medical treatment cabin | |
| CN212460653U (en) | Disinfection access control management system | |
| JPWO2018138343A5 (en) | ||
| CN107085663A (en) | System for realizing self-medicine service | |
| CN111803046A (en) | Isolation self-service health sign index detection booth | |
| CN112198214A (en) | Electrospray extraction ionization mass spectrometry detection system for new coronary pneumonia | |
| CN109949945A (en) | A kind of intelligent sharing first-aid method and system | |
| Weijer | Another tuskegee? | |
| CN112227772B (en) | Movable intelligent sorting workstation for preventing and controlling new coronary pneumonia | |
| CN213607734U (en) | Medical treatment cabin | |
| CN114376809A (en) | Motion function detection and evaluation system | |
| KR102406096B1 (en) | Untact Sorting Clinic Booth | |
| CN113096764A (en) | Medical physiotherapy recommendation system and method based on intelligent medicine chest | |
| CN109492948A (en) | Catering system intelligent disinfecting Internet-based services control platform | |
| CN111507190A (en) | Intelligent prevention and control channel | |
| CN109410106A (en) | Educational system intelligent disinfecting Internet-based services control platform |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |